Risperidone Depot (Microspheres) [Risperidone] in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder - an Open-Label Follow-up Trial of RIS-INT-62 and RIS-INT-85.
Phase of Trial: Phase III
Latest Information Update: 24 May 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions; Registrational
- Sponsors Janssen
- 21 May 2010 Actual patient number (314) added as reported by ClinicalTrials.gov.
- 06 Feb 2008 Status changed from in progress to completed according to ClinicalTrials.gov
- 19 Nov 2007 Status changed from completed to in progress.